BIOMARKERS FOR IDENTIFYING ESOPHAGEAL CANCER PATIENTS FOR TREATMENT WITH AN ANTI-EGFR DRUG

• 收藏
• 分享

专利权人:

发明人:

Henry Qixiang Li,Jie Yang,Jianyun Deng

申请号：

US14418693

公开号：

US20150218647A1

申请日:

2013.07.31

申请国别(地区):

US

年份:

2015

代理人:

摘要：

The present invention provides methods for the treatment of esophageal cancer patients as well as the identification and selection of esophageal cancer patients for treatment with an anti-EGFR agent treatment including anti-EGFR antibody treatment, e.g., cetuximab treatment. In some embodiments, the drug is against a heterodimer formed by EGFR and another member of the ErbB receptor family such as EfbB2/Her2/neu.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/